Sugi Predict

Sugi Predict / Compounds / Ethyl Acetate

Ethyl Acetate

Ethyl Acetate

SCHEMBL902253

CCOC(C)=O.c1ccncc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.61
▸ LMNA P02545 2/20 0.61
▸ HSD17B10 Q99714 2/20 0.61
▸ TSHR P16473 3/20 0.40
▸ NAPRT Q6XQN6 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CDC7 O00311 2/20 0.37
▸ DBF4 Q9UBU7 2/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL11599396 1.00 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL11661625 1.00 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL27540812 0.98 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL7281476 0.98 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL27535761 0.98 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL38324 0.98 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL11434031 0.96 ALDH1A1 (0.56) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL7589907 0.96 ALDH1A1 (0.56) ALDH1A1LMNAHSD17B10TSHRNAPRT
Cyclohexane SCHEMBL933417 0.94 ALDH1A1 (0.54) ALDH1A1LMNAHSD17B10TSHRNAPRT
Ethyl Acetate SCHEMBL11222752 0.94 ALDH1A1 (0.54) ALDH1A1LMNAHSD17B10TSHRNAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119161299-A Preparation method of anti-schizophrenia drug blonanserin 湖南大学 2024-12-20 — — CN claimed
CN-114133406-A Conjugated organic complex of europium (III) and preparation method and application thereof 南京邮电大学 2022-03-04 — — CN claimed
US-20170368019-A1 CRYSTAL FORMS OF SCUTELLARIN AGLYCONE AND PREPARATION THEREOF HLK PHARMACEUTICALS CO., LTD. (CN) 2017-12-28 — — US claimed
CN-103204901-B Taxol sews the preparation method of thing altogether INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2016-03-09 — — CN claimed
CN-104592184-A Scutellarin aglycone crystal form and preparation method thereof YUNNAN INST MATERIA MEDICA 2015-05-06 — — CN claimed
CN-102888208-B Abrasive and substrate polishing method HITACHI CHEMICAL CO LTD 2015-02-25 — — CN claimed
CN-100518790-C Quality control method for vatility source preparation CHENGDU JOINT WIT PHARMACEUTIC (CN) 2009-07-29 — — CN claimed
CN-1328278-C N-acylamino acid amide compounds and intermediates for preparation thereof UBE INDUSTRIES (JP) 2007-07-25 — — CN claimed
CN-1623996-A N-acyl glucosamine and preparation method thereof HUNAN SCIENCE & TECHNOLOGY UNI (CN) 2005-06-08 — — CN claimed
CN-1265661-A N-acylamino acid amide compounds and intermediates for preparation thereof UBE INDUSTRIES (JP) 2000-09-06 — — CN claimed
CN-119161299-A Preparation method of anti-schizophrenia drug blonanserin 湖南大学 2024-12-20 — — CN disclosed
CN-117736415-A Cyanuric chloride cross-linked and pyridine-terminated cross-linked poly-biphenyl piperidinium hydroxide ion exchange membrane, and preparation method and application thereof 清华大学 2024-03-22 — — CN disclosed
CN-116514624-A N-monofluoromethyl carbonyl compound and preparation method thereof 中山大学附属第一医院 2023-08-01 — — CN disclosed
CN-114133406-A Conjugated organic complex of europium (III) and preparation method and application thereof 南京邮电大学 2022-03-04 — — CN disclosed
CN-111491932-A 6- (morpholin-4-yl) -pyridin-2-yl-1H-pyrrolo [3,2-B ] pyridine derivatives as M-TOR inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2020-08-04 — — CN disclosed
US-4379146-A Substituted phosphonamides as antihypertensives MERCK & CO., INC. (US) 1983-04-05 — — US disclosed
EP-0058427-A2 Substituted phosphonamides, a process for preparing the same and a pharmaceutical composition which is useful in the treatment of hypertension MERCK & CO. INC. (US) 1982-08-25 — — EP disclosed
EP-0052991-A1 Carboxyalkyl amino acid derivatives of various substituted prolines E.R. Squibb & Sons, Inc. (US) 1982-06-02 — — EP disclosed
US-4181669-A A CARBODIIMIDE WITH ACID CATALYSTS AS A CONDENSATION AGENT AKTIEBOLAGET LEO (SE) 1980-01-01 — — US disclosed
US-4180504-A Method for the preparation of esters AKTIEBOLAGET LEO (SE) 1979-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170368019-A1 CRYSTAL FORMS OF SCUTELLARIN AGLYCONE AND PREPARATION THEREOF PCSK9, PROC, PCSK7 ALDH1A1 3288/4885LMNA 2217/4885HSD17B10 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.